Answer
For Vipdomet, infant risk cannot be excluded: metformin enters human milk in small amounts, while alogliptin excretion into human milk is unknown, so a decision is needed to stop breastfeeding or stop/avoid Vipdomet, weighing breastfeeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- Alogliptin/Metformin Hydrochloride 12.5 mg/1000 mg film-coated tabletsTakeda UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 12Document updated
Sources checked